[Analysis of pregnancy outcome after chemotherapy of XXXX ].

@entity1 @entity2208 @entity249 @entity154 @entity1466 @entity65700 @entity1469 @entity600 @entity1500
The pregnancy outcome of 57 @entity1 who had been treated for @entity1469 , between 1975 and 1982, was studied. All @entity1 had regular menstrual cycle within six months after the last chemotherapy. Frequency of secondary @entity249 is 5% (3/60). No correlation between the amount of chemotherapy and secondary @entity249 was apparent. Of eighty-three pregnancies in 57 @entity1 , 55 pregnancies or 66.3% terminated in full term deliveries, 4 or 4.8% terminated in premature deliveries. Eleven of the 83 or 11.3% ended in @entity2208 .4% in recurrent hydatiditorm mole. Only one @entity1 (1.7%) had @entity600 . There was no increase in fetal wastage or @entity154 when compared with pregnancies prior to chemotherapy or after untreated molar @entity1 . Among the 59 live born @entity1 , 4 or 6.8% @entity1 belong to light for date, 49 or 83.1% to appropriate for date and 6 or 10.2% to heavy for date. Chemotherapic agents, mainly @entity1500 and @entity65700 , appeared to have no effect on fetal growth. The incidence of @entity1466 subsequent to pregnancy in treated @entity1 was 1.8% (1/57) and was 0.6% (2/365) in untreated molar @entity1 (n.s.).
